Hutchin Hill Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-10,400
| Closed | -$1.26M | – | 1101 |
|
|
2017
Q1 | $1.26M | Sell |
10,400
-18,200
| -64% | -$2.21M | 0.03% | 414 |
|
|
2016
Q4 | $3.5M | Buy |
+28,600
| New | +$3.5M | 0.12% | 203 |
|
|
2015
Q1 | – | Sell |
-9,400
| Closed | -$1.74M | – | 820 |
|
|
2014
Q4 | $1.74M | Buy |
9,400
+3,000
| +47% | +$555K | 0.06% | 255 |
|
|
2014
Q3 | $1.06M | Sell |
6,400
-16,100
| -72% | -$2.67M | 0.04% | 353 |
|
|
2014
Q2 | $3.52M | Sell |
22,500
-2,500
| -10% | -$391K | 0.16% | 93 |
|
|
2014
Q1 | $3.8M | Sell |
25,000
-36,250
| -59% | -$5.51M | 0.2% | 81 |
|
|
2013
Q4 | $8.14M | Buy |
61,250
+17,250
| +39% | +$2.29M | 0.56% | 40 |
|
|
2013
Q3 | $5.11M | Buy |
44,000
+26,700
| +154% | +$3.1M | 0.46% | 47 |
|
|
2013
Q2 | $1.6M | Buy |
+17,300
| New | +$1.6M | 0.16% | 89 |
|